Colin Biggin
Patrimonio netto: 7 M $ in data 30/06/2026
Patrimonio netto: 7 M $ in data 30/06/2026
Colin Biggin is currently a Member at The Royal Society of Chemistry and the Society of Nuclear Medicine & Molecular Imaging.
Since 2017, Dr. Biggin has been Chief Operating Officer at Clarity Pharmaceuticals Ltd., with the COO title starting in 2026.
Dr. Biggin completed undergraduate and doctorate degrees at the University of Glasgow.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 08/04/2026 | 4.926.458 ( 1,32% ) | 7 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CLARITY PHARMACEUTICALS LTD | Direttore operativo | 11/10/2024 |
The Royal Society of Chemistry
The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services Professional organization for the chemical sciences | Corporate Officer/Principal | - |
Society of Nuclear Medicine & Molecular Imaging
Society of Nuclear Medicine & Molecular Imaging Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit scientific and professional organization that promotes the science, technology and practical application of nuclear medicine and molecular imaging | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
University of Glasgow
University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal Society of Chemistry
The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services Professional organization for the chemical sciences | Commercial Services |
Society of Nuclear Medicine & Molecular Imaging
Society of Nuclear Medicine & Molecular Imaging Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit scientific and professional organization that promotes the science, technology and practical application of nuclear medicine and molecular imaging | Commercial Services |
Clarity Pharmaceuticals Ltd.
Clarity Pharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops radiopharmaceutical products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale